A Study on Establishment of Phytochemical Analysis of Ethanolic Extract of Silybum Marianum (L.) Gaertn. (Milk Thistle) Seed Extract
Abstract
Keywords
Full Text:
PDFReferences
Shah SMM, Khan FA, Shah SMH, Chishti KA, Pirzada S, Khan MA, Farid A. Evaluation of phytochemicals and antimicrobial activity of white and blue capitulum and whole plant of Silybum marianum. 2011;World Appl Sci J. 12: 1139- 1144.
Lee D. Y. W and Y. Liu. Molecular structure and stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, isolated from Silybum marianum (Milk Thistle). Journal of Natural Products. 2003; 66: 1171-1174.
Czygan F.C, Frohne D, Holtzel C., Nagell A, Pfander H.J, Willuhn and Buff, W. In: Bisset NG .ed. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis1994;. Medpharm Scientific Publishers, Stuttgart.
Parisoto C C, Constantin R P, Maeda A. S. J, Constantin R. P, Yamamoto N. S, Bracht A, Ishii-Iwamoto E. L.. Constantin and Jorgete. Metabolic effects of silibinin in the rat liver. 2011; 11-25.
Giribabu N, Eswar Kumar K, Swapna Rekha S, Muniandy S, Salleh N. Vitis vinifera (Muscat Variety) seed ethanolic extract preserves activity levels of enzymes and histology of the liver in adult male rats with diabetes. Evid Based Complement Alternat Med. 2015; 2015:542026. doi: 10.1155/2015/542026.
Giribabu N, Karim K, Kilari EK, Kassim NM, Salleh N. Anti-inflammatory, antiapoptotic and proproliferative effects of vitis vinifera seed ethanolic extract in the liver of streptozotocin-nicotinamide-induced type 2 diabetes in male rats. Can J Diabetes. 2018; 42:138–49. doi: 10.1016/j.jcjd.2017.04.005.
Irondi EA, Oboh G, Akindahunsi AA. Antidiabetic effects of Mangifera indica Kernel Flour-supplemented diet in streptozotocin-induced type 2 diabetes in rats. Food Sci Nutr. 2016; 4:828–39. doi: 10.1002/fsn3.348.
Parisoto C C, Constantin R P, Maeda A. S. J, Constantin R. P, Yamamoto N. S, Bracht A, Ishii-Iwamoto E. L.. Constantin and Jorgete. 2011. Metabolic effects of silibinin in the rat liver. 11-25.
Atlas de la Diabetes de la FID-Octava edición, International Diabetes Federation, 2017.
Erejuwa OO, Nwobodo NN, Akpan JL, Okorie UA, Ezeonu CT, Ezeokpo BC, et al. Nigerian honey ameliorates hyperglycemia and dyslipidemia in alloxan-induced diabetic rats. Nutrients. 2016; 8:95. doi: 10.3390/nu8030095.
Rayar A and R. Manivannan, “In-vitro alpha-amylase and alpha-glucosidase inhibition activity of umbelliferone and beta-ionone isolated from Coriandrum sativum Linn,” 2016.World Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 1, pp. 1280–1289,. View at Google Scholar.
Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10:3–12. [PubMed] [Google Scholar].
Xu Y, He Z, King GL. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Curr Diab Rep.2005; 5:91–7. doi: 10.1007/s11892-005-0034-z.
Jung HA, Islam MD, Kwon YS, Jin SE, Son YK, Park JJ, et al. Extraction and identification of three major aldose reductase inhibitors from Artemisia montana. Food Chem Toxicol. 2011;49:376–384. [PubMed] [Google Scholar].
Mane P.B, Antre R.V, Oswal R.J. Antidiabetic drugs: An overview. Int. J. Pharm. Chem. Sci. 2012;1:301–306. [Google Scholar].
Lorenzati B, Zucco C, Miglietta S, Lamberti F, Bruno G. Oral hypoglycemic drugs: pathophysiological basis of their mechanism of actionoral hypoglycemic drugs: pathophysiological basis of their mechanism of action. Pharmaceuticals. 2010; 3:3005–3020. doi: 10.3390/ph3093005.
Gupta PD, De A. Diabetes Mellitus and its herbal treatment. Int J Res Pharm Biomed Sci. 2012; 3:706–21.Availableonline.
Ju C, Yue W, Yang Z, Zhang Q, Yang X, Liu Z, et al. Antidiabetic effect and mechanism of chitooligosaccharides. Biol Pharm Bull. 2010 33:1511–6. doi: 10.1248/bpb.33.1511.
Li L., Zeng J., Gao Y., He D. Targeting silibinin in the antiproliferative pathway. Expert Opin Investig Drugs2010; 19: 243–255. doi:10.1517/13543780903
British Pharmacopoeia Commission. British Pharmacopoeia. European Commission. New Delhi: Department of health, social services and public safety, medicine and health care predict regulations agency. 2010; A-2.88-2.89.
Khandelwal KR. Practical pharmacognosy techniques and experiments. New Delhi: Nirali Prakashan. 2002; p. 15-163.
Kokate CK. Practical Pharmacognosy. 1st ed. New Delhi: Vallabh Prakashan. 2005;. p. 111.
Kumar D, Gupta J, Kumar S, Arya R, Kumar T, Gupta G . Pharmacognostic evaluation of Cayratia trifolia (Linn.) leaf. Asian Pac J Trop Biomed.2012; 2(1):6-10.
Patel DK, Kumar R, Prasad SK, Hemalatha S. Pedalium murex Linn (Pedaliaceae) fruits: A comparative antioxidant activity of its different fractions. Asian Pac J Trop Biomed. 2011;1:395–400. [PMC free article] [PubMed] [Google Scholar].
Patel DK, Kumar R, Prasad SK, Sairam K, Hemalatha S. Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed. 2011;1:316–322. [PMC free article] [PubMed] [Google Scholar].
Pearson Thomas A. Cardiovascular Disease in Developing Countries: Myths, Realities, and Opportunities. Cardiovascular Drugs and Therapy.1999; 13:95-104.
Akpan E. J, Okokon, J. E, and Offong E. Antidiabetic and hypolipidemic activities of ethanolic leaf extract and fractions of Melanthera scandens. 2012; Asian Pac. J. Trop. Biomed. 2, 523–527. doi: 10.1016/S2221-1691(12)60089-6.
Rajaei Z, Hadjzadeh M.-A.-R, Moradi R, Ghorbani A, and Saghebi A. Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Securigera securidaca seeds in streptozotocin-induced diabetic rats2015;. Adv. Biomed. Res. 4:33. doi: 10.4103/2277-9175.150427.
Khan HB, Vinayagam KS, Moorthy BT, Palanivelu S, Panchanatham S. Anti-inflammatory and anti-hyperlipidemic effect of Semecarpus anacardium in a high fat diet: STZ-induced type 2 diabetic rat model. Inflammopharmacology. 2013; 21:37–46. doi: 10.1007/s10787-011-0109-1.
Burkhardt RJC. Hyperlipidemia and cardiovascular disease: new insights on lipoprotein (a). Curr Opin Lipidol. 2019; 30:260–1. doi: 10.1097/MOL.0
Ference BA, Kastelein JJ, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, et al. Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease. JAMA. 2019; 321:364–73. doi: 10.1001/jama.20
20045.
Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982; 28:2077–80.
Refbacks
- There are currently no refbacks.